| 1 | MMV | MultiMetaVerse Holdings Limited | $1.12 | 89.57% | 4.042 M | MultiMetaVerse Holdings Limited26 days ago MULTIMETAVERSE HOLDINGS LIMITED RECEIVES NASDAQ NOTIFICATION REGARDING MINIMUM BID PRICE AND MINIMUM MARKET VALUE OF LISTED SECURITIES News shanghai , april 23, 2024 /prnewswire/ -- multimetaverse holdings limited (the "company"), an animation and entertainment company for young consumers in china, announced today that it has received written notifications (the "notification letters") from the nasdaq stock market llc ("nasdaq") dated april 17, 2024, notifying the company that nasdaq listing rule 5550(a)(2) requires companies to maintain a minimum bid price of $1.00 per share and nasdaq listing rule 5550(b)(2) requires companies to maintain a minimum market value of listed securities of $35 million. nasdaq listing rule 5810(c)(3)(a) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days and nasdaq listing rule 5810(c)(3)(c) provides that a failure to meet the minimum market value of listed securities requirement exists if the deficiency continues for a period of 30 consecutive business days. News 26 days ago | N/A |
| 2 | SISI | Shineco, Inc. | $1.32 | 37.5% | 3.859 M | Shineco, Inc.18 days ago SHINECO DEVELOPS REVOLUTIONARY NEW PRODUCT WITH VARIED APPLICATIONS TO POSITIVELY IMPACT THE HEALTH CARE INDUSTRY News beijing , may 1, 2024 /prnewswire/ -- shineco, inc. ("shineco" or the "company"; nasdaq: sisi), a provider of technologically advanced healthcare products and services, announced today that its subsidiaries fuzhou medashan biotechnology co., ltd. and kaifeng yixi biotechnology co., ltd. News 18 days ago | N/A |
| 3 | CPHI | China Pharma Holdings, Inc. | $0.43 | 31.14% | 1.627 M | China Pharma Holdings, Inc.3 months ago CHINA PHARMA HOLDINGS INC. ANNOUNCES 1-FOR-5 REVERSE STOCK SPLIT News haikou, china , feb. 23, 2024 /prnewswire/ -- china pharma holdings inc. ("china pharma" or the "company") (nyse american: cphi) reported that it expects to implement a 1-for-5 reverse stock split on its common stock effective wednesday, march 6, 2024, with trading to begin on a split-adjusted basis at the market open on that day. trading in the common stock will continue on the nyse american under the symbol "cphi". News 3 months ago | N/A |
| 4 | SXTC | China SXT Pharmaceuticals, Inc. | $1.4 | 21.74% | 1.121 M | China SXT Pharmaceuticals, Inc.7 months ago CHINA SXT PHARMACEUTICALS, INC. REGAINED COMPLIANCE WITH NASDAQ'S MINIMUM BID PRICE RULE News taizhou, china, oct. 26, 2023 (globe newswire) -- china sxt pharmaceuticals, inc. ("sxtc" or the "company"), (nasdaq: sxtc), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of traditional chinese medicine pieces ("tcmps"), including advanced tcmps (directly-oral tcmp and after-soaking-oral tcmp), fine tcmps, regular tcmps, and tcm homologous supplements ("tcmhs"), today announced that on october 19, 2023, nasdaq notified us that it has determined that for the 10 consecutive business days, from october 5, 2023 to october 13, 2023, the closing bid price of the company's ordinary shares has been at $1.00 per share or greater. accordingly, the company has regained compliance with listing rule 5550(a)(2) and nasdaq has closed this matter. News 7 months ago | N/A |
| 5 | PWM | Prestige Wealth Inc. | $1.24 | 20.38% | 10.846 K | Prestige Wealth Inc.6 months ago PRESTIGE WEALTH INC. ANNOUNCES FIRST HALF OF FISCAL YEAR 2023 FINANCIAL RESULTS News hong kong , dec. 1, 2023 /prnewswire/ -- prestige wealth inc. (nasdaq: pwm) (the "company" or "prestige wealth"), a wealth management and asset management services provider based in hong kong, today announced its unaudited financial results for the six months ended march 31, 2023. mr. hongtao shi, the company's chairman and chief executive officer, commented, "reflecting upon the first half of fiscal year 2023, we faced some undeniable headwinds in our wealth management business, largely stemming from the ramifications of the covid-19 pandemic. News 6 months ago | N/A |
| 6 | IONM | Assure Holdings Corp. | $0.4901 | 14.78% | 156.148 K | Assure Holdings Corp.2 days ago ASSURE & DANAM RESCHEDULE CORPORATE UPDATE CALL & WEBCAST News denver, may 17, 2024 (globe newswire) -- assure holdings corp. (the “company” or “assure”) (nasdaq: ionm), a provider of intraoperative neuromonitoring (“ionm”) and remote neurology services, announced today that management has rescheduled the joint corporate update call with danam for wednesday, may 22, 2024 at 4:00 pm eastern time. conference call information date: wednesday, may 22, 2024time: 4:00 pm eastern timetoll free: 1-877-545-0523international: 1-973-528-0016participant access code: 229289webcast link: https://www.webcaster4.com/webcast/page/2566/50637 conference call replay information toll free: 1-877-481-4010international: 1-919-882-2331replay passcode: 50637webcast replay: https://www.webcaster4.com/webcast/page/2566/50637 about assure holdings assure holdings corp. is a provider of outsourced intraoperative neuromonitoring and remote neurology services. News 2 days ago | Buy |
| 7 | GTBP | GT Biopharma, Inc. | $3.5 | 12.18% | 3.41 K | GT Biopharma, Inc.4 days ago GT BIOPHARMA REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE News brisbane, california, may 15, 2024 (globe newswire) -- gt biopharma, inc. (the “company”) (nasdaq: gtbp), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the company's proprietary natural killer (nk) cell engager, trike® platform, today announced first quarter 2024 financial results for the period ended march 31, 2024. News 4 days ago | Buy |
| 8 | AIHS | Senmiao Technology Limited | $0.9994 | 11.04% | 1 K | Senmiao Technology Limited2 months ago SENMIAO TECHNOLOGY REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT News chengdu, china , march 28, 2024 /prnewswire/ -- senmiao technology limited ("senmiao" or the "company") (nasdaq: aihs), a financing and servicing company focused on the online ride-hailing industry in china as well as an operator of its own online ride-hailing platform, today announced that it has received a letter from the nasdaq listing qualifications staff, dated march 26, 2024, notifying the company that it has regained compliance with the minimum bid price requirement under the listing rules of the nasdaq stock market. the letter noted that as a result of the closing bid price of the company's common stock having been at $1.00 per share or greater for 20 consecutive business days, from february 27, 2024 to march 25, 2024, the company has regained compliance with listing rule 5550(a)(2), and the matter is now closed. News 2 months ago | N/A |
| 9 | MLSS | Milestone Scientific, Inc. | $0.7545 | 10.63% | 2.565 K | Milestone Scientific, Inc.3 days ago MILESTONE SCIENTIFIC REPORTS REVENUE OF $2.2 MILLION AND PROVIDES BUSINESS UPDATE FOR THE FIRST QUARTER OF 2024 News sales through new online portal increase 31% over the same period last year gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year reports steady progress on reimbursement strategy for the compuflo® epidural system roseland, n.j., may 16, 2024 (globe newswire) -- milestone scientific inc. (nyse: mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and announces financial results for the first quarter ended march 31, 2024. News 3 days ago | N/A |
| 10 | DBGI | Digital Brands Group, Inc. | $2.88 | 10.34% | 3.72 K | Digital Brands Group, Inc.2 days ago DIGITAL BRANDS GROUP TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON MONDAY, MAY 20, 2024 News austin, tx, may 17, 2024 (globe newswire) -- digital brands group, inc. (“dbg”) (nasdaq: dbgi), a curated collection of luxury lifestyle, digital-first brands, will report financial results for the first quarter ended march 30, 2024 on monday, may 20, 2024 at 9:30 a.m. et. News 2 days ago | N/A |
| 11 | IKT | Inhibikase Therapeutics, Inc. | $1.9 | 9.83% | 2.323 K | Inhibikase Therapeutics, Inc.3 days ago INHIBIKASE THERAPEUTICS REPORTS FIRST QUARTER FINANCIAL RESULTS AND HIGHLIGHTS RECENT PERIOD ACTIVITY News company to host conference call on thursday, may 16, 2024 at 8:00 a.m. et company to host conference call on thursday, may 16, 2024 at 8:00 a.m. et News 3 days ago | Hold |
| 12 | FFIE | Faraday Future Intelligent Electric Inc. | $1.13 | 9.7% | 73.94 M | Faraday Future Intelligent Electric Inc.1 day ago FARADAY FUTURE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 EARNINGS WEBCAST TIMING News los angeles--(business wire)--faraday future intelligent electric inc. (nasdaq: ffie) (“faraday future,” “ff,” or the “company”), a california-based global shared intelligent electric mobility ecosystem company, today announced that it is scheduled to have a conference call on its fourth quarter and full year 2023 results after market close on tuesday, may 28, 2024 at 5:00 p.m. pacific time (8:00 p.m. eastern time). interested investors and other parties can listen to a webcast of the conferenc. News 1 day ago | N/A |
| 13 | GNLX | Genelux Corporation | $3.99 | 9.32% | 9.799 K | Genelux Corporation10 days ago GENELUX CORPORATION REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES GENERAL BUSINESS UPDATES News westlake village, calif., may 09, 2024 (globe newswire) -- genelux corporation (nasdaq: gnlx), a late clinical-stage immuno-oncology company, today announced financial results for the first quarter of 2024 and provided general business updates. News 10 days ago | Buy |
| 14 | STAF | Staffing 360 Solutions, Inc. | $0.36 | 9.09% | 27.767 K | Staffing 360 Solutions, Inc.26 days ago STAFFING 360 SOLUTIONS RECEIVES NASDAQ NOTIFICATION RELATED TO NON-TIMELY FILING OF ITS 2023 FORM 10-K News new york, april 23, 2024 (globe newswire) -- staffing 360 solutions, inc. ( nasdaq: staf ) (“staffing 360” or the “company”), a company executing a buy-integrate-build strategy through the acquisition of staffing organizations in the united states, today reported that it received a letter from the listing qualifications department of the nasdaq stock market llc (“nasdaq”) notifying the company that it is not in compliance with the requirements of nasdaq listing rule 5250(c)(1) (the “nasdaq listing rule”) as a result of not having timely filed its annual report on form 10-k with the securities and exchange commission (“sec”) for the period ended december 30, 2023. News 26 days ago | Sell |
| 15 | CNEY | CN Energy Group Inc. | $0.72 | 8.27% | 13.227 K | CN Energy Group Inc.2 months ago CN ENERGY GROUP. INC. TO PRESENT AT THE AEGIS CAPITAL CORP 2024 VIRTUAL CONFERENCE News lishui, china , april 4, 2024 /prnewswire/ -- cn energy group. inc. (nasdaq: cney) (the "company" or "cn energy group"), a high-tech enterprise specializing in cogeneration of high-quality wood-activated carbon and clean energy, today announced that steven berman, chief executive officer of cn energy group, will participate in the aegis capital corp 2024 virtual conference scheduled for tuesday, may 7th, 2024, at 4pm eastern time. News 2 months ago | N/A |
| 16 | NMHI | Nature's Miracle Holding Inc. | $0.7292 | 8.19% | 3.4 K | Nature's Miracle Holding Inc.3 days ago NATURE'S MIRACLE AND AGRIFY CORPORATION ANNOUNCE SIGNING OF THE DEFINITIVE MERGER AGREEMENT News transaction expected to close in the second half of 2024 ontario, calif. , may 16, 2024 /prnewswire/ -- nature's miracle holding inc. (nasdaq: nmhi) ("nature's miracle" or the "company"), a leader in vertical farming technology and infrastructure, and agrify corporation (nasdaq: agfy) ("agrify"), announced today that both parties have signed a definitive agreement and plan of merger ("agreement") in which a new wholly-owned subsidiary of nature's miracle will merge with and into agrify, with agrify surviving the merger as a wholly-owned subsidiary of nature's miracle. News 3 days ago | N/A |
| 17 | TAOP | Taoping Inc. | $0.8634 | 8.06% | 18.596 K | Taoping Inc.4 days ago TAOPING REPORTS 25% YOY INCREASE IN APRIL CONTRACT REVENUE News shenzhen, china , may 15, 2024 /prnewswire/ -- taoping inc. (nasdaq: taop, the "company"), a developer of innovative smart cloud platform services and solutions, new media and artificial intelligence solutions, today reported a total contract revenue value of rmb 20.8 million (approximately usd $2.9 million) for the month of april 2024, representing an increase of 25% compared to the month of april 2023. the company highlighted that its impressive growth was driven by its commitment to innovation, as evident by the increased demand for its wide array of ai-based products, including its smart city solutions. News 4 days ago | N/A |
| 18 | IPW | iPower Inc. | $3.12 | 7.96% | 479.495 K | iPower Inc.13 days ago DATASEA PRE-ANNOUNCES ESTIMATED REVENUE OF $12.5 MILLION FOR APRIL 2024 SUPPORTING ITS PRIOR REVENUE GUIDANCE OF $86 MILLION FOR FISCAL 2024 News dtss on track to achieve record revenue for fiscal 2024 as it further penetrates china's $528 billion 5g market beijing , may 6, 2024 /prnewswire/ -- datasea inc. (nasdaq: dtss) ("datasea" or the "company"), a digital technology company incorporated in nevada and engaged in innovative business segments for acoustic high tech and 5g-ai multimodal communication technology in china, pre-announced estimated revenue of approximately $12.5 million for the month of april 2024. this revenue, which is mainly attributable to datasea's 5g multimodal communication business, supports the company's revenue previously announced guidance of $86 million for its full fiscal year, representing a 1,128% year-over-year increase. News 13 days ago | N/A |
| 19 | MKFG | Markforged Holding Corporation | $0.4966 | 7.93% | 17.079 K | Markforged Holding Corporation11 days ago MARKFORGED ANNOUNCES FIRST QUARTER 2024 RESULTS News waltham, mass., may 08, 2024 (globe newswire) -- markforged holding corporation (nyse: mkfg) (the “company”), the company strengthening manufacturing resiliency by enabling industrial production at the point of need, today announced its financial results for the first quarter ended march 31, 2024. News 11 days ago | Buy |
| 20 | TBLT | ToughBuilt Industries, Inc. | $3.28 | 7.89% | 847 | ToughBuilt Industries, Inc.24 days ago TOUGHBUILT INDUSTRIES ANNOUNCES RECEIPT OF NASDAQ DELINQUENCY NOTICE News irvine, calif., april 25, 2024 (globe newswire) -- toughbuilt industries, inc. (nasdaq: tblt), announced that on april 19, 2024, it received a staff determination notice from the listing qualifications department of the nasdaq stock market llc (“nasdaq”) informing the company that since the company has not yet filed its annual report on form 10-k for the fiscal year ended december 31, 2023 (the “annual report”), the company was no longer in compliance with nasdaq listing rule 5250(c)(1) (the “listing rule”). News 24 days ago | N/A |
| 21 | HLTH | Cue Health Inc. | $0.104 | 7.88% | 685.018 K | Cue Health Inc.5 days ago CUE HEALTH EVALUATING WARNING LETTER RECEIVED FROM FOOD AND DRUG ADMINISTRATION (FDA) News san diego--(business wire)--cue health inc. (nasdaq: hlth), a healthcare technology company (the “company”), has received a warning letter from the fda about its emergency use authorized (eua) covid-19 test. the company is currently evaluating the letter and determining its response, with more information to follow in the next few days. about cue cue health inc. (nasdaq: hlth) is a healthcare technology company that empowers healthcare providers to streamline their ability to deliver value-base. News 5 days ago | Hold |
| 22 | ARBB | ARB IOT Group Limited | $0.913 | 7.87% | 12.36 K | N/A | Buy |
| 23 | SCLX | Scilex Holding Company | $0.9699 | 7.77% | 107.44 K | Scilex Holding Company5 days ago SCILEX HOLDING COMPANY ANNOUNCES FINAL COURT APPROVAL OF A SETTLEMENT AGREEMENT WITH TAKEDA PHARMACEUTICALS TO RESOLVE THE PARAGRAPH IV PATENT INFRINGEMENT LAWSUIT RELATING TO SCILEX'S INTENT TO EXPAND THE LABEL FOR ITS FDA-APPROVED LIQUID COLCHICINE PRODUCT, GLOPERBA® News palo alto, calif., may 14, 2024 (globe newswire) -- scilex holding company (nasdaq: sclx, “scilex” or “company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that the 45-day review period for the u.s. federal trade commission and u.s. department of justice to comment on or object to the settlement agreement (the “settlement agreement”) entered into by the company and its wholly owned subsidiary, scilex pharmaceuticals inc. (“scilex pharma” and, together with the company, the “scilex parties”) with takeda pharmaceuticals u.s.a., inc. and takeda pharmaceuticals company ltd. (collectively “takeda”) to resolve the paragraph iv patent infringement lawsuit (the “action”) that takeda filed against the scilex parties in the federal district court in delaware in november 2023 has expired and the u.s. district court for the district of delaware entered a consent judgment on may 3, 2024, approving the settlement agreement. the action arose from scilex's filing of a revised label with the fda seeking to expand the label for its fda-approved liquid colchicine product, gloperba®, a preventive treatment for gout. as part of the settlement agreement, the scilex parties entered into a license agreement with takeda granting the company and its affiliates a non-exclusive license to certain patents owned by takeda. the terms of those agreements are confidential. News 5 days ago | Buy |
| 24 | ALBT | Avalon GloboCare Corp. | $0.2999 | 7.65% | 3.018 K | Avalon GloboCare Corp.27 days ago AVALON GLOBOCARE ANNOUNCES LAUNCH OF U.S. SALES OF KETOAIR BREATHALYZER AT THE HACK YOUR HEALTH BY KETOCON 2024 CONFERENCE News freehold, n.j., april 22, 2024 (globe newswire) -- avalon globocare corp. (“avalon” or the “company”) (nasdaq: albt), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today announced the official launch of the ketoair™ breathalyzer device and related accessories in the u.s. at the hack your health by ketocon 2024 conference being held from may 31 to june 2, 2024 in austin, texas. News 27 days ago | N/A |
| 25 | WNW | Meiwu Technology Company Limited | $1.13 | 7.62% | 727.55 K | Meiwu Technology Company Limited4 months ago MEIWU TECHNOLOGY CO., LIMITED REGAINS COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS News shenzhen, china, jan. 18, 2024 (globe newswire) -- meiwu technology co., limited (nasdaq: wnw) (“meiwu” or the “company”), an online and mobile commerce company providing organic and green food products to customers on its online platform and in its stores, enterprise short message service (“sms”) and information technology to serve designated medical insurance institutions in china. the company today announced on january 9, 2024, it received notice from the nasdaq office of general counsel that the bid price deficiency of meiwu's ordinary shares has been cured, and meiwu has regained compliance with nasdaq marketplace rule 5550(a)(2). News 4 months ago | N/A |
| 26 | ZVIA | Zevia PBC | $1.13 | 7.62% | 6.767 K | Zevia PBC11 days ago ZEVIA ANNOUNCES FIRST QUARTER 2024 RESULTS News los angeles--(business wire)--zevia pbc (“zevia” or the “company”) (nyse: zvia), the company bringing naturally delicious, zero sugar, clean-label beverages across usage occasions today reported results for the first quarter ended march 31, 2024. first quarter 2024 highlights net sales decreased 10.4% year over year to $38.8 million unit volume decreased 10.4% year over year to 3.0 million equivalized cases gross profit margin was 45.7%, down 0.8 percentage points year over year but up 5.0 perc. News 11 days ago | Buy |
| 27 | ELDN | Eledon Pharmaceuticals, Inc. | $3.25 | 7.62% | 6.145 K | Eledon Pharmaceuticals, Inc.10 days ago ELEDON PHARMACEUTICALS REPORTS FIRST QUARTER 2024 OPERATING AND FINANCIAL RESULTS News completed oversubscribed $50 million private placement first participant dosed in clinical trial at university of chicago medicine assessing the use of tegoprubart to prevent islet cell transplant rejection in patients with type 1 diabetes reported updated data from ongoing phase 1b trial evaluating tegoprubart for prevention of rejection in kidney transplantation tegoprubart used as part of immunosuppressive treatment following the first-ever kidney xenotransplant irvine, calif., may 09, 2024 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn) today reported its first quarter 2024 operating and financial results and reviewed recent business highlights. News 10 days ago | Buy |
| 28 | TLPH | Talphera, Inc. | $1.16 | 7.41% | 1.681 K | Talphera, Inc.3 days ago TALPHERA TO PARTICIPATE AT A.G.P. VIRTUAL HEALTHCARE CONFERENCE News san mateo, calif. , may 16, 2024 /prnewswire/ -- talphera, inc. (nasdaq: tlph), ("talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that management will participate in a fireside chat at the a.g.p. News 3 days ago | N/A |
| 29 | YS | YS Biopharma Co., Ltd. | $1.05 | 7.37% | 1.607 K | YS Biopharma Co., Ltd.12 days ago YS BIOPHARMA TO HOLD EXTRAORDINARY GENERAL MEETING ON MAY 21, 2024 AND ANNOUNCES THE APPOINTMENT OF INTERIM CHIEF EXECUTIVE OFFICER News gaithersburg, md. , may 7, 2024 /prnewswire/ -- ys biopharma co., ltd. News 12 days ago | N/A |
| 30 | AZTR | Azitra Inc | $0.195 | 7.14% | 85.917 K | Azitra Inc2 days ago AZITRA, INC. ANNOUNCES POSITIVE PRECLINICAL DATA FROM ATR-04 PRESENTED AT THE SOCIETY OF INVESTIGATIVE DERMATOLOGY ANNUAL MEETING News branford, conn.--(business wire)--azitra, inc. (nyse american: aztr), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced preclinical data from the company's platform and pipeline. the data are being presented on friday, may 17, 2024, in two oral sessions entitled “staphylococcus epidermidis for the topical treatment of epidermal growth factor receptor (egfr) inhibitor-induced dermal toxicity” and “cutaneous delivery o. News 2 days ago | N/A |
| 31 | CVM | Cel-Sci Corporation | $1.36 | 7.09% | 8.086 K | Cel-Sci Corporation3 days ago CEL-SCI CORPORATION REPORTS SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS News vienna, va.--(business wire)---- $cvm #multikine--cel-sci corporation reports second quarter fiscal 2024 financial results. News 3 days ago | Buy |
| 32 | VISL | Vislink Technologies, Inc. | $5.46 | 7.07% | 100 | Vislink Technologies, Inc.1 month ago VISLINK LAUNCHES DRAGONFLY V: A REVOLUTION IN MINIATURIZED WIRELESS VIDEO TRANSMISSION News the company's smallest-ever transmitter will debut at nab 2024 mt. olive, new jersey, april 11, 2024 (globe newswire) -- vislink technologies, inc. (“vislink” or the “company”) (nasdaq: visl), a global technology leader in the capture, delivery, and management of high-quality live video and associated data in the media and entertainment, law enforcement, and defense markets, today announced the release of dragonfly v, an ultra-compact hevc hdr cofdm transmitter. News 1 month ago | Buy |
| 33 | MAPS | WM Technology, Inc. | $1.07 | 7% | 459.359 K | WM Technology, Inc.2 days ago WM TECHNOLOGY, INC. ANNOUNCES NOTIFICATION OF DELINQUENCY WITH NASDAQ News irvine, calif.--(business wire)--wm technology, inc. (“wm technology” or the “company”) (nasdaq: maps), announced it received an expected delinquency notification letter from nasdaq's listing qualifications department on may 14, 2024 which indicated that the company was not in compliance with nasdaq listing rule 5250(c)(1) (the “listing rule”) as a result of the company's failure to timely file its quarterly report on form 10-q for the quarter ended march 31, 2024 (“quarterly report”) and its c. News 2 days ago | Buy |
| 34 | IPDN | Professional Diversity Network, Inc. | $1.01 | 6.95% | 928 | Professional Diversity Network, Inc.4 days ago PROFESSIONAL DIVERSITY NETWORK, INC. ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2024 News chicago, may 15, 2024 (globe newswire) -- professional diversity network, inc. (nasdaq:ipdn), (“ipdn” or the “company”), a global developer and operator of online and in-person networks that provides access to networking, training, educational and employment opportunities for diverse individuals, today announced its financial results for the quarter ended march 31, 2024. “our first quarter showed a mixed bag within our revenue streams. News 4 days ago | N/A |
| 35 | INM | InMed Pharmaceuticals Inc. | $0.315 | 6.82% | 158.77 K | InMed Pharmaceuticals Inc.5 days ago INMED PHARMACEUTICALS REPORTS THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE News reported positive preclinical data in both its alzheimer's and dry amd programs closed fiscal q3 with cash position of us$7.9 million vancouver, british columbia--(newsfile corp. - may 14, 2024) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, today announced financial results and business update for the third quarter of the fiscal year 2024, which ended march 31, 2024. the company's full financial statements and related md&a for the third quarter ended march 31, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov. News 5 days ago | Buy |
| 36 | PHGE | BiomX Inc. | $0.3618 | 6.79% | 393 | BiomX Inc.4 days ago BIOMX TO HOST FIRST QUARTER 2024 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST ON MAY 21, 2024 News gaithersburg, maryland and ness ziona, israel, may 15, 2024 (globe newswire) -- biomx inc. (nyse american: phge) (“biomx” or the “company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the company will host a conference call and a live audio webcast on tuesday, may 21, 2024, at 8:00 a.m. et, to report first quarter 2024 financial results and provide business and program updates. News 4 days ago | N/A |
| 37 | ALUR | Allurion Technologies, Inc. | $1.89 | 6.78% | 1.726 K | Allurion Technologies, Inc.4 days ago ALLURION ANNOUNCES THREE SCIENTIFIC PRESENTATIONS AT THE EUROPEAN CONGRESS ON OBESITY, INCLUDING STUDY ON LEAN MASS PRESERVATION FOR SUSTAINABLE, HEALTHY WEIGHT LOSS News natick, mass.--(business wire)---- $alur #allurion--allurion technologies, inc. (nyse: alur), a company dedicated to ending obesity, today announced three scientific presentations at the 31st european congress on obesity (eco) held in venice, italy, on 12-15 may, 2024. presentations include data from a study of 712 patients treated with the allurion program, which is anchored by the allurion balloon and enhanced by the virtual care suite featuring allurion's proprietary behavior change program. this study was cond. News 4 days ago | N/A |
| 38 | FGEN | FibroGen, Inc | $1.28 | 6.67% | 64.121 K | FibroGen, Inc12 days ago FIBROGEN TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES News san francisco, may 07, 2024 (globe newswire) -- fibrogen, inc. (nasdaq: fgen) today announced that the company's management will participate in the following investor conferences: News 12 days ago | Buy |
| 39 | DDC | DDC Enterprise Limited | $0.789 | 6.62% | 2.03 K | DDC Enterprise Limited23 days ago DDC ENTERPRISE LIMITED REPORTS ON NYSE AMERICAN NONCOMPLIANCE NOTICE News new york, april 26, 2024 (globe newswire) -- ddc enterprise limited (nyse american: ddc) (“daydaycook” or the “company”) announced today that on april 23, 2024, the company received notice from nyse american (the “exchange”) that the company currently is below the exchange's continued listing standards set forth in section 1003(a)(i) of the nyse american company guide, which requires the company to have stockholders' equity of $2.0 million or more if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. the exchange indicated that because the company reported stockholders' deficit of $(222,572,936) on june 30, 2023 and losses from continuing operations and/or net losses in its two most recent fiscal years ended december 31, 2022, the company was not in compliance with section 1003(a)(i) of the company guide. News 23 days ago | N/A |
| 40 | SOC | Sable Offshore Corp. | $14.67 | 6.61% | 6.416 K | Sable Offshore Corp.4 days ago SABLE OFFSHORE CORP. REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATES News houston--(business wire)--sable offshore corp. reports first quarter 2024 financial results and provides operational updates. News 4 days ago | N/A |
| 41 | TANH | Tantech Holdings Ltd. | $0.7 | 6.54% | 60.99 K | Tantech Holdings Ltd.27 days ago TANTECH HOLDINGS LTD ANNOUNCES $2.1 MILLION PRIVATE PLACEMENT News lishui, china , april 22, 2024 /prnewswire/ -- tantech holdings ltd (nasdaq: tanh) ("tantech" or the "company") today announced that it has entered into a securities purchase agreement with institutional investors to raise approximately $2.1 million in aggregate cash proceeds, before deducting fees to the placement agent and other offering expenses payable by the company. the closing of the private placement is expected to occur on april 24, 2024, subject to the satisfaction of certain customary closing conditions set forth in the securities purchase agreement. News 27 days ago | N/A |
| 42 | LAKE | Lakeland Industries, Inc. | $17.98 | 6.52% | 2.586 K | Lakeland Industries, Inc.18 days ago LAKELAND INDUSTRIES DECLARES CASH DIVIDEND FOR SECOND QUARTER 2025 News huntsville, al / accesswire / may 1, 2024 / lakeland industries, inc. (nasdaq:lake) (the "company" or "lakeland"), a leading global manufacturer of protective clothing for industry, healthcare and first responders on the federal, state, and local levels, today announced that its board of directors declared a cash dividend for its fiscal second quarter of 2025 of $0.03 per share. the dividend will be paid on may 22, 2024, to stockholders of record as of may 15, 2024. News 18 days ago | Buy |
| 43 | CDMO | Avid Bioservices, Inc. | $9.7 | 6.36% | 348.338 K | Avid Bioservices, Inc.2 days ago SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF AVID BIOSERVICES, INC. - CDMO News new york , may 16, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of avid bioservices, inc. ("avid" or the "company") (nasdaq: cdmo). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext. News 2 days ago | Buy |
| 44 | PRST | Presto Automation, Inc. | $0.2284 | 6.23% | 324.326 K | Presto Automation, Inc.5 days ago PRESTO TO REPORT FISCAL THIRD QUARTER 2024 FINANCIAL RESULTS News san carlos, calif., may 14, 2024 (globe newswire) -- presto automation inc. (nasdaq: prst ), one of the largest drive-thru ai and automation technology providers to the restaurant industry, today announced that the company will release its fiscal third quarter 2024 financial results on monday, may 20, 2024, after the financial markets close. News 5 days ago | Buy |
| 45 | SLE | Super League Enterprise, Inc. | $1.4 | 6.06% | 1.108 K | Super League Enterprise, Inc.4 days ago SUPER LEAGUE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS News ~ q1 2024 revenues increase 27% from q1 2023 to $4.2 million ~ ~ strategic partnerships formed with chartis and gstv ~ santa monica, calif., may 15, 2024 (globe newswire) -- super league (nasdaq: sle) (the “company”), a leading creator and publisher of content experiences and media solutions across the world's largest immersive platforms, has released its first quarter 2024 financial results in the form of a shareholder letter. News 4 days ago | Buy |
| 46 | CPTN | Cepton, Inc. | $2.98 | 6.05% | 2.863 K | Cepton, Inc.6 days ago CEPTON, INC. REPORTS FIRST QUARTER 2024 RESULTS News san jose, calif.--(business wire)---- $cptn #automotive--cepton reports first quarter 2024 results. News 6 days ago | Buy |
| 47 | AVDL | Avadel Pharmaceuticals plc | $16.42 | 6% | 34.502 K | Avadel Pharmaceuticals plc11 days ago AVADEL PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News -- generated $27.2 million in net revenue from sales of lumryz™ -- -- through march 31, greater than 2,800 patients enrolled in avadel's ryzup patient support services and more than 1,700 patients initiated therapy -- News 11 days ago | Buy |
| 48 | UK | Ucommune International Ltd | $2.3 | 5.99% | 19.126 K | Ucommune International Ltd25 days ago GARRETT OLIVER UNITES BREWING INDUSTRY IN PIONEERING 'BREWING FOR IMPACT' INITIATIVE News brooklyn, n.y.--(business wire)--for over three decades garrett oliver, the james beard award winning brewmaster of brooklyn brewery, has continued to be a beacon of innovation in the craft beer movement, skillfully blending his passion for crafting exceptional beers with a steadfast commitment to social change within the industry and beyond. in celebration of his 30th anniversary with brooklyn brewery this year, oliver is proud to unveil the "brewing for impact" campaign, an initiative that no. News 25 days ago | N/A |
| 49 | CEAD | CEA Industries Inc. | $0.7948 | 5.97% | 1.519 K | CEA Industries Inc.5 days ago CEA INDUSTRIES INC. REPORTS FIRST QUARTER 2024 RESULTS AND PROVIDES UPDATE ON STRATEGIC REVIEW PROCESS News louisville, colorado, may 14, 2024 (globe newswire) -- cea industries inc. (nasdaq: cead, ceadw) (“cea industries” or the “company”), is reporting results for the three months ended march 31, 2024. News 5 days ago | N/A |
| 50 | TUP | Tupperware Brands Corporation | $2.33 | 5.91% | 1.291 M | Tupperware Brands Corporation26 days ago NEW TUPPERWARE® WOWPOP POPCORN MAKER AND ULTIMATE SILICONE BAGS WIN INTERNATIONAL RED DOT AWARDS FOR OUTSTANDING PRODUCT DESIGN News orlando, fla. , april 23, 2024 /prnewswire/ -- tupperware has earned two new recognitions for innovation in product design - receiving the internationally prestigious red dot awards for outstanding product design - for the new tupperware® wowpop microwave popcorn maker and the new collection of tupperware® ultimate silicone slim bags. News 26 days ago | Buy |
| 51 | ROMA | Roma Green Finance Limited | $0.81 | 5.88% | 64.097 K | Roma Green Finance Limited4 months ago ROMA GREEN FINANCE LIMITED ANNOUNCES PRICING OF $12,300,000 PUBLIC OFFERING News hong kong, jan. 09, 2024 (globe newswire) -- roma green finance limited (nasdaq: roma) (the “company”), a cayman islands exempted company that is based in hong kong, today announced the pricing of a public offering of 2,449,943 of its ordinary shares at a public offering price of $4.00 per share for aggregate gross proceeds of approximately $9,799,772 prior to deducting underwriting discounts, commissions and other related expenses. additionally, in connection with the initial public offering, a selling shareholder is selling 625,517 ordinary shares at $4.00 per share, for total gross proceeds of $2,502,068, before deducting underwriting discounts, commissions and other related expenses. the company will not receive any of the proceeds from the sale by the selling shareholder. the ordinary shares are expected to begin trading on the nasdaq capital market tomorrow, january 9, 2024, under the trading symbol “roma.” the offering is expected to close on or about january 11, 2024, subject to customary closing conditions. News 4 months ago | N/A |
| 52 | VEEE | Twin Vee PowerCats Co. | $0.6783 | 5.82% | 146 | Twin Vee PowerCats Co.4 days ago TWIN VEE POWERCATS CO. REPORTS RESULTS FOR FIRST QUARTER 2024 OPERATIONS News fort pierce, fl / accesswire / may 15, 2024 / twin vee powercats co. (nasdaq:veee) ("twin vee" or the "company"), a designer, manufacturer and distributor of recreational and commercial power boats, today reported operational highlights and financial results for three months ended march 31, 2024. highlights for three months ended march 31, 2024: (all comparisons are to the three months ended march 31, 2023 unless otherwise noted) revenue for the three months ending march 31, 2024, decreased by 41% to $5,276,000 from $8,877,000 in the corresponding period of the previous year. News 4 days ago | N/A |
| 53 | CASI | CASI Pharmaceuticals, Inc. | $3.49 | 5.76% | 897 | CASI Pharmaceuticals, Inc.4 days ago CASI PHARMACEUTICALS RECEIVES FDA CLEARANCE ON THE INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR CID-103 IN IMMUNE THROMBOCYTOPENIA (ITP) News beijing , may 15, 2024 /prnewswire/ -- casi pharmaceuticals, inc. (nasdaq: casi), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic and pharmaceutical products announced today the following: on april 12, 2024 casi submitted the ind application to the fda for cid-103 to support a phase 1/2 study of cid-103 in adults with chronic immune thrombocytopenia (itp). on may 13, 2024 casi received a letter from fda indicating that study may proceed. News 4 days ago | Buy |
| 54 | VINC | Vincerx Pharma, Inc. | $0.73 | 5.71% | 1.541 K | Vincerx Pharma, Inc.5 days ago VINCERX PHARMA REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE News vincerx continued to progress phase 1 dose-escalation studies for vip943, a potentially best-in-class anti-cd123 antibody-drug conjugate (adc), and vip236, a first-in-class small molecule-drug conjugate (smdc) News 5 days ago | Buy |
| 55 | AGBA | AGBA Group Holding Limited | $2.6 | 5.69% | 66.447 K | AGBA Group Holding Limited4 days ago AGBA SOLIDIFIES MARKET LEADERSHIP WITH EXPANSION PLANS AND FOCUS ON TECH/FINTECH INNOVATION News los angeles, may 15, 2024 (globe newswire) -- nasdaq-listed, agba group holding limited (“agba” or the “company” or the “group”), the leading one-stop financial supermarket in hong kong released its financial results for the first quarter of 2024. News 4 days ago | N/A |
| 56 | ITRM | Iterum Therapeutics plc | $1.49 | 5.67% | 1.408 K | Iterum Therapeutics plc6 days ago ITERUM THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News - -nda resubmitted; fda action expected in early q4 24-- - -cash runway into 2025, including through potential fda approval-- News 6 days ago | Buy |
| 57 | NCPL | Netcapital Inc. | $0.1389 | 5.63% | 821.676 K | Netcapital Inc.11 days ago NETCAPITAL PURSUES BROKER-DEALER LICENSE TO INCREASE POTENTIAL REVENUE GENERATION News boston--(business wire)---- $ncpl #earnings--netcapital inc. (nasdaq: ncpl, ncplw) (the “company”), a digital private capital markets ecosystem, today announced that its wholly-owned subsidiary, netcapital securities inc., has applied for broker-dealer registration with the financial industry regulatory authority (“finra”). this marks a significant step in the company's evolution as it looks to expand upon its current service offerings and support private companies with larger and later stage financings than are c. News 11 days ago | N/A |
| 58 | CTM | Castellum, Inc. | $0.269 | 5.53% | 100 | Castellum, Inc.4 days ago CASTELLUM, INC. ANNOUNCES FIRST QUARTER FINANCIAL RESULTS News vienna, va., may 15, 2024 (globe newswire) -- castellum, inc. (the "company") (nyse-american: ctm), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces highlights of its operating results for its first quarter ended march 31, 2024. News 4 days ago | N/A |
| 59 | ALLG | Allego N.V. | $0.9523 | 5.52% | 5.711 K | Allego N.V.3 days ago ALLEGO N.V. FILES ANNUAL REPORT ON FORM 20-F FOR 2023 News arnhem, netherlands--(business wire)--allego n.v. (“allego” or the “company”) (nyse: allg) announces that on may 16, 2024, it filed with the securities and exchange commission its annual report on form 20-f that included audited financial statements for the year ended december 31, 2023. the company's annual report on form 20-f is available online at the company's website at www.allego.eu and also online at www.sec.gov. shareholders have the ability to receive a hard copy of the company's comple. News 3 days ago | N/A |
| 60 | BAOS | Baosheng Media Group Holdings Limited | $3.9 | 5.41% | 15.914 K | Baosheng Media Group Holdings Limited3 years ago BAOSHENG MEDIA GROUP HOLDINGS LIMITED REPORTS FINANCIAL RESULTS FOR THE FIRST HALF OF 2021 News beijing, china, sept. 30, 2021 (globe newswire) -- baosheng media group holdings limited (nasdaq: baos) (“baosheng” or the “company”), a china-based online marketing solution provider, today announced its financial results for the first half of 2021. News 3 years ago | N/A |
| 61 | PZG | Paramount Gold Nevada Corp. | $0.5363 | 5.4% | 284.225 K | Paramount Gold Nevada Corp.2 months ago BLM ISSUES NOTICE OF INTENT FOR PARAMOUNT GOLD'S PROPOSED HIGH-GRADE GRASSY MOUNTAIN GOLD AND SILVER MINE News winnemucca, nev., march 19, 2024 (globe newswire) -- paramount gold nevada corp. (nyse american: pzg) (“paramount” or the “company”) is pleased to announce that the bureau of land management (“blm”) has filed the notice of intent (the “notice” or “noi”) in the federal registry, thereby initiating the preparation of an environmental impact statement (“eis”) in compliance with the national environmental policy act (“nepa”) process for the proposed grassy mountain mine. News 2 months ago | Hold |
| 62 | ONMD | OneMedNet Corp | $0.49 | 5.38% | 3.055 K | OneMedNet Corp17 days ago ONEMEDNET CORPORATION ANNOUNCES PARTICIPATION IN THE EF HUTTON ANNUAL GLOBAL CONFERENCE News minneapolis, minnesota--(newsfile corp. - may 2, 2024) - onemednet corporation (nasdaq: onmd), is the leading curator of precision curated regulatory-grade real world data (“rwd”), will be participating in the ef hutton annual global conference, which will take place on may 15, 2024 at the plaza hotel in new york. aaron green, president & ceo and dr. jeffrey yu, founder & cmo, will be presenting on may 15th. News 17 days ago | N/A |
| 63 | ZVRA | Zevra Therapeutics, Inc. | $4.98 | 5.29% | 15.193 K | Zevra Therapeutics, Inc.11 days ago ZEVRA THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND CORPORATE UPDATES News full commercial launch of olpruva at the end of january 2024, with market access growing to ~ 75% of covered lives as of may 1, 2024 News 11 days ago | Buy |
| 64 | SING | SinglePoint Inc. | $0.22 | 5.26% | 305.467 K | SinglePoint Inc.20 days ago SINGLEPOINT TO PRESENT AT THE PLANET MICROCAP SHOWCASE: VEGAS 2024 News phoenix, arizona--(newsfile corp. - april 29, 2024) - singlepoint inc. (cboe: sing) ("singlepoint" or "the company"), an innovative solar energy company, announces that wil ralston, chief executive officer, will present a corporate overview at the planet microcap showcase: vegas 2024. the conference is being held on april 30 - may 2, 2024 at the paris hotel & casino in las vegas, nv. News 20 days ago | N/A |
| 65 | PRFX | PainReform Ltd. | $0.89 | 5.26% | 1.554 K | PainReform Ltd.4 days ago PAINREFORM PROVIDES BUSINESS UPDATE FOR THE FIRST QUARTER OF 2024 News reaches 50% e nrollment in the s econd p art of its phase 3 c linical t rial of prf-110 in b unionectomy News 4 days ago | N/A |
| 66 | TPHS | Trinity Place Holdings Inc. | $0.1479 | 5.12% | 96.264 K | Trinity Place Holdings Inc.3 months ago TRINITY PLACE HOLDINGS INC. DISCLOSES COMMUNICATION FROM NYSE AMERICAN News new york--(business wire)--trinity place holdings inc. discloses communication from nyse american. News 3 months ago | N/A |
| 67 | FCUV | Focus Universal Inc. | $0.314 | 5.02% | 1.258 K | Focus Universal Inc.23 days ago FOCUS UNIVERSAL INC. ANNOUNCES BOARD APPROVAL FOR SPIN-OFF OF LUSHER INC. News ontario, ca and los angeles, ca / accesswire / april 26, 2024 / focus universal inc. (nasdaq:fcuv) ("focus" or the "company"), a provider of patented hardware and software design technologies for internet of things (iot) and 5g, today announced the board of directors has approved the spin-off lusher inc. to develop the sec financial reporting ai-driven automation software for a future initial public offering and a potential nasdaq listing. chief executive officer desheng wang stated, "we are excited that our management team received authorization from our board of directors to start the spin-off process for lusher inc. lusher inc. which will focus on ai-driven automation software development and commercialization, which enables focus universal to concentrate more on the core of universal smart iot. News 23 days ago | N/A |
| 68 | DC | Dakota Gold Corp. | $3.15 | 5% | 14.721 K | Dakota Gold Corp.4 days ago DAKOTA GOLD CORP. ANNOUNCES MEETING RESULTS News lead, south dakota--(newsfile corp. - may 15, 2024) - dakota gold corp. (nyse american: dc) ("dakota gold" or the "company") is pleased to announce that all proposals were approved at the annual meeting of stockholders held on tuesday, may 14, 2024 in lead, south dakota (the "meeting"). a total of 56,478,574 or 66.65% of the company's issued and outstanding shares were represented at the meeting. News 4 days ago | Buy |
| 69 | ACET | Adicet Bio, Inc. | $1.68 | 5% | 46.349 K | Adicet Bio, Inc.5 days ago ADICET REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES News redwood city, calif. & boston--(business wire)--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for autoimmune diseases and cancer, today reported financial results and operational highlights for the first quarter ended march 31, 2024. “we are poised for a transformational year in 2024 as we advance our gamma delta t cell platform in autoimmune diseases and prepare to initiate a phase 1 study evaluating o. News 5 days ago | Buy |
| 70 | LUCD | Lucid Diagnostics Inc. | $0.9502 | 4.99% | 927 | Lucid Diagnostics Inc.5 days ago PAVMED PROVIDES BUSINESS UPDATE AND FIRST QUARTER 2024 FINANCIAL RESULTS News lucid strengthens balance sheet and secures a july 17, 2024 moldx pre-submission meeting date veris health completes mou with the ohio state's james cancer hospital conference call and webcast to be held tomorrow, may 14 th at 8:30 am edt new york , may 13, 2024 /prnewswire/ -- pavmed inc. (nasdaq: pavm, pavmz) ("pavmed" or the "company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the company and its subsidiaries, lucid diagnostics inc. (nasdaq: lucd) ("lucid") and veris health inc. ("veris"), and presented financial results for the company for the three months ended march 31, 2024. conference call and webcast the webcast will take place on tuesday, may 14, 2024, at 8:30 am and is accessible in the investor relations section of the company's website at pavmed.com. News 5 days ago | Buy |
| 71 | EYPT | EyePoint Pharmaceuticals, Inc. | $12.43 | 4.98% | 109.698 K | EyePoint Pharmaceuticals, Inc.3 days ago EYEPOINT PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4) News watertown, mass., may 16, 2024 (globe newswire) -- eyepoint pharmaceuticals, inc. (nasdaq: eypt), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the company granted non-statutory stock options to new employees as inducement awards outside the company's 2023 long-term incentive plan in accordance with nasdaq listing rule 5635(c)(4). News 3 days ago | Buy |
| 72 | QLGN | Qualigen Therapeutics, Inc. | $0.3076 | 4.98% | 685 | Qualigen Therapeutics, Inc.1 month ago QUALIGEN THERAPEUTICS' NOVEL DIRECT PAN-RAS INHIBITORS PRESENTED AT AMERICAN ASSOCIATION OF CANCER RESEARCH (AACR) 2024 ANNUAL MEETING News poster includes preclinical data on novel direct pan-ras inhibitors carlsbad, calif., april 10, 2024 (globe newswire) -- qualigen therapeutics, inc. (“qualigen” or “the company,” nasdaq: qlgn) today announces a poster presentation on its preclinical novel direct pan-ras inhibitors was presented at the american association for cancer research (aacr) annual meeting 2024 held april 5 – 10 in san diego, california. News 1 month ago | N/A |
| 73 | ANGI | Angi Inc. | $2.32 | 4.98% | 21.941 K | Angi Inc.5 days ago IAC TO PARTICIPATE IN THE 52ND ANNUAL J.P. MORGAN GLOBAL TECHNOLOGY, MEDIA AND COMMUNICATIONS CONFERENCE News new york , may 14, 2024 /prnewswire/ -- iac (nasdaq: iac) will participate in the 52nd annual j.p. morgan global technology, media and communications conference on wednesday, may 22, 2024. News 5 days ago | Buy |
| 74 | ADTX | Aditxt, Inc. | $2.11 | 4.98% | 674 | Aditxt, Inc.4 days ago EVOFEM BIOSCIENCES ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2024 News san diego , may 15, 2024 /prnewswire/ -- the company behind the hormone-free contraceptive phexxi® (lactic acid, citric acid and potassium bitartrate), evofem biosciences, inc. ("evofem" or "the company") (otcqb: evfm) today announced financial results for the first quarter of 2024. highlights of and since the quarter include: received $1 million from aditxt, inc. (nasdaq: adtx) in may 2024 in consideration for reinstating and amending the merger agreement, as amended, between the companies. News 4 days ago | N/A |
| 75 | SERA | Sera Prognostics, Inc. | $8.67 | 4.96% | 12.016 K | Sera Prognostics, Inc.11 days ago SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News salt lake city , may 8, 2024 /prnewswire/ -- sera prognostics inc., the pregnancy company® (nasdaq: sera), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the first quarter of 2024 ended march 31, 2024. recent highlights: submitted manuscript of prime study interim analysis results for peer-reviewed publication. News 11 days ago | Hold |
| 76 | ALZN | Alzamend Neuro, Inc. | $0.665 | 4.96% | 916 | Alzamend Neuro, Inc.12 days ago ALZAMEND NEURO ANNOUNCES TERMINATION OF AT-THE-MARKET EQUITY OFFERING PROGRAM News atlanta--(business wire)---- $alzn #10_day_termination_process_started--alzamend neuro announces termination of at-the-market equity offering program. News 12 days ago | Buy |
| 77 | RCAT | Red Cat Holdings, Inc. | $1.06 | 4.95% | 9.317 K | Red Cat Holdings, Inc.24 days ago RED CAT SUCCESSFULLY PASSES FIELD TESTING WITH DOODLE LABS AGAINST ELECTRONIC WARFARE TECHNOLOGY IN UKRAINE News san juan, puerto rico, april 25, 2024 (globe newswire) -- red cat holdings, inc. (nasdaq: rcat) ("red cat"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announced it has successfully passed electronic warfare (ew) testing in ukraine with doodle labs. the successful test is part of a continuous innovation cycle that began in may 2023 with a partnership between doodle labs and red cat for its u.s. army short range reconnaissance (srr) program prototype. News 24 days ago | N/A |
| 78 | EPIX | ESSA Pharma Inc. | $5.98 | 4.91% | 851 | ESSA Pharma Inc.5 days ago ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS FINANCIAL RESULTS FOR FISCAL SECOND QUARTER ENDED MARCH 31, 2024 News combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in psa in phase 1 dose escalation in patients with mcrpc naïve to second generation antiandrogens, including 81% of patients achieving psa90, 69% of patients achieving psa90 in less than 90 days, and 63% of patients achieving psa News 5 days ago | N/A |
| 79 | REE | REE Automotive Ltd. | $5.24 | 4.91% | 1.428 K | REE Automotive Ltd.2 days ago REE AUTOMOTIVE TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 30, 2024 News tel aviv, israel, may 17, 2024 (globe newswire) -- ree automotive ltd. (nasdaq: ree) (“ree” or the “company”), an automotive technology company and provider of full by-wire electric trucks and platforms, today announced it will report its first quarter 2024 financial results before market open on thursday, may 30, 2024. News 2 days ago | Buy |
| 80 | ATRA | Atara Biotherapeutics, Inc. | $0.6399 | 4.9% | 43.987 K | Atara Biotherapeutics, Inc.10 days ago ATARA BIOTHERAPEUTICS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL PROGRESS News thousand oaks, calif.--(business wire)---- $atra #cart--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic epstein-barr virus (ebv) t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported financial results for the first quarter 2024, recent business highlights, and key upcoming milestones for 2024. "our lead car t program, ata3219, is advancing as a promising new therapeutic option for oncolo. News 10 days ago | Sell |
| 81 | BFI | BurgerFi International Inc | $0.4132 | 4.87% | 2.065 K | BurgerFi International Inc4 days ago BURGERFI REPORTS FIRST QUARTER 2024 RESULTS News fort lauderdale, fla., may 15, 2024 (globe newswire) -- burgerfi international, inc. (nasdaq: bfi, bfiiw) (“burgerfi” or the “company”), owner of burgerfi, one of the nation's leading fast-casual “better burger” dining brands, and anthony's coal fired pizza & wings (“anthony's”), the high-quality, casual dining pizza brand, today reported financial results for the first quarter ended april 1, 2024. News 4 days ago | Buy |
| 82 | MOBX | Mobix Labs, Inc. | $2.62 | 4.8% | 896 | Mobix Labs, Inc.5 days ago MOBIX LABS, INC. ANNOUNCES SECOND QUARTER 2024 FINANCIAL RESULTS News irvine, calif.--(business wire)--mobix labs, inc. (nasdaq: mobx) (“mobix labs” or the “company”), a fabless semiconductor company developing disruptive next-generation connectivity solutions for wired, wireless 5g, military, defense, aerospace, and medical industries, today announced its financial results for the fiscal second quarter ended march 31, 2024. “i am excited about march quarter's execution on foundational milestones including our entering into a definitive agreement for the synergis. News 5 days ago | N/A |
| 83 | MWG | Multi Ways Holdings Limited | $0.32 | 4.78% | 200 | Multi Ways Holdings Limited3 days ago MULTI WAYS HOLDINGS REPORTS ROBUST FINANCIAL PERFORMANCE IN FISCAL YEAR 2023 RESULTS News singapore, may 16, 2024 (globe newswire) -- multi ways holdings limited (“multi ways” or the “company”) (nyse american: mwg), a leading supplier of a wide range of heavy construction equipment for sales and rental in singapore and the surrounding region, today announced fiscal year 2023 financial results. News 3 days ago | N/A |
| 84 | ALCE | Alternus Clean Energy, Inc. | $0.3492 | 4.77% | 95.28 K | Alternus Clean Energy, Inc.3 days ago ALTERNUS CLEAN ENERGY PARTNERS WITH B2I DIGITAL TO EXECUTE A COMPREHENSIVE INVESTOR COMMUNICATION AND EDUCATION INITIATIVE News fort mill, south carolina--(newsfile corp. - may 16, 2024) - alternus clean energy, inc. (nasdaq: alce), a leading utility-scale transatlantic, clean energy independent power producer (ipp), announced it has engaged b2i digital to conduct an investor engagement, education and awareness program. b2i digital will leverage its targeted marketing expertise to increase awareness of alternus' unique position in the renewable energy sector and its potential for growth among the investment community. News 3 days ago | N/A |
| 85 | MRVI | Maravai LifeSciences Holdings, Inc. | $11.86 | 4.77% | 273.189 K | Maravai LifeSciences Holdings, Inc.10 days ago MARAVAI LIFESCIENCES ANNOUNCES MAY AND JUNE 2024 INVESTOR CONFERENCE SCHEDULE News san diego, may 09, 2024 (globe newswire) -- maravai lifesciences, inc. (nasdaq: mrvi), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the months of may and june. News 10 days ago | Buy |
| 86 | SEEL | Seelos Therapeutics, Inc. | $1.99 | 4.76% | 3.499 K | Seelos Therapeutics, Inc.2 days ago SEELOS THERAPEUTICS ANNOUNCES PRICING OF $1.1 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES News new york , may 16, 2024 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel) ("seelos" or the "company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("cns") disorders and rare diseases, announced today that it has entered into a securities purchase agreement with certain institutional investors, providing for the purchase and sale of 380,968 shares of common stock and pre-funded warrants to purchase up to 81,239 shares of common stock at a price of $2.46 per share (or $2.459 per pre-funded warrant) in a registered direct offering priced at-the-market under nasdaq rules, resulting in total gross proceeds of approximately $1.1 million, before deducting the placement agent's fees and other estimated offering expenses. the company also agreed to issue to the investors unregistered warrants to purchase up to 924,414 shares of common stock in a concurrent private placement. News 2 days ago | Buy |
| 87 | ADD | Color Star Technology Co., Ltd. | $0.265 | 4.74% | 91.994 K | Color Star Technology Co., Ltd.6 months ago COLOR STAR TECHNOLOGY RECEIVED NASDAQ NOTIFICATION LETTER REGARDING BID PRICE DEFICIENCY News new york, nov. 16, 2023 (globe newswire) -- color star technology co., ltd. (nasdaq: add) ("color star" or the "company"), an entertainment technology company with a global network that focuses on the application of technology and artificial intelligence in the entertainment industry, announced today that on november 14, 2023, the company received a notification letter from the nasdaq listing qualifications staff of the nasdaq stock market llc (“nasdaq”) notifying the company that the minimum bid price per share for its class a ordinary shares has been below $1.00 for a period of 30 consecutive business days and the company therefore no longer meets the minimum bid price requirements set forth in nasdaq listing rule 5550(a)(2). News 6 months ago | N/A |
| 88 | CGEN | Compugen Ltd. | $2.21 | 4.74% | 3.434 K | Compugen Ltd.3 days ago COMPUGEN PUBLISHES PAPER IN CANCER IMMUNOLOGY RESEARCH ON UNIQUE BIOLOGY OF PVRIG AND ITS THERAPEUTIC POTENTIAL News holon, israel, may 16, 2024 /prnewswire/ -- compugen ltd. (nasdaq: cgen) (tase: cgen) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the online publication of a peer reviewed paper titled "pvrig is expressed on stem-like t cells in dendritic cell-rich niches in tumors and its blockade may induce immune infiltration in non-inflamed tumors" link, in cancer immunology research, a journal of the american association for cancer research. News 3 days ago | Buy |
| 89 | PRPL | Purple Innovation, Inc. | $1.55 | 4.73% | 15.941 K | Purple Innovation, Inc.12 days ago PURPLE INNOVATION REPORTS FIRST QUARTER 2024 RESULTS News lehi, utah , may 7, 2024 /prnewswire/ -- purple innovation, inc. (nasdaq: prpl), a comfort innovation company known for creating the "world's first no pressure ™ mattress," today announced results for the first quarter ended march 31, 2024, which were in line with guidance. first quarter financial summary (comparisons versus first quarter 2023) 1 net revenue increased 12.5% to $120.0 million compared to $106.7 million. News 12 days ago | Hold |
| 90 | LSAK | Lesaka Technologies, Inc. | $5.1 | 4.72% | 307 | Lesaka Technologies, Inc.10 days ago SHAREHOLDER INVESTIGATION: HALPER SADEH LLC INVESTIGATES LSAK, SLCA News new york , may 9, 2024 /prnewswire/ -- halper sadeh llc, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: lesaka technologies, inc. (nasdaq: lsak)'s merger with adumo rf (pty) ltd. if you are a lesaka shareholder, click here to learn more about your rights and options. News 10 days ago | N/A |
| 91 | XELA | Exela Technologies, Inc. | $2.67 | 4.71% | 1.033 K | Exela Technologies, Inc.4 days ago EXELA TECHNOLOGIES HOLDINGS, INC. REPORTS FIRST QUARTER 2024 RESULTS News first quarter highlights revenue of $258.8 million, down 5.4% year-over-year gross margin of 22.0%, up 1.1% year-over-year interest expense of $21.1m, down 52.3% year-over-year sg&a of $40.9m, down 7.9% year-over-year operating profit of $0.1m versus a loss of $6.9 million year-over year net loss of $25.6 million ($24.9 million attributable to exela technologies inc), an improvement of $19.9 million year-over-year adjusted ebitda of $12.9m, down 11.1% year-over-year irving, texas, may 15, 2024 (globe newswire) -- exela technologies, inc. (“exela” or the “company”) (nasdaq: xela, xelap), a global business process automation (“bpa”) leader, announced today its financial results for the first quarter 2024. “our results show improvement across many operating metrics. News 4 days ago | Hold |
| 92 | SVRA | Savara, Inc. | $4.69 | 4.69% | 74.006 K | Savara, Inc.3 days ago SAVARA ANNOUNCES NEW EMPLOYMENT INDUCEMENT GRANT News austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee. on may 14, 2024, the compensation committee of savara's board of directors granted the inducement awards to a new employee who recently joined the company. the inducement awards consist of options to purchase 15,000 shares of the company's common stock and restricted stock units (rsus) cover. News 3 days ago | Buy |
| 93 | MLNK | MeridianLink, Inc. | $18.84 | 4.67% | 18.135 K | MeridianLink, Inc.12 days ago MERIDIANLINK REPORTS FIRST QUARTER 2024 RESULTS News costa mesa, calif.--(business wire)---- $mlnk--meridianlink, inc. (nyse: mlnk) announced financial results for the first quarter ended march 31, 2024. News 12 days ago | Buy |
| 94 | BENF | Beneficient | $4.04 | 4.66% | 2.036 K | Beneficient16 days ago BENEFICIENT REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE RULE News dallas, may 03, 2024 (globe newswire) -- beneficient (the “company”) (nasdaq: benf), a technology-enabled platform providing liquidity and related trust and custody services to holders of alternative assets through its proprietary online platform, altaccess, today announced that it has received notice from the nasdaq stock market llc (“nasdaq”) that it has regained compliance with the minimum bid price requirement under nasdaq listing rule 5550(a)(2). the notice confirmed that the company's securities will continue to be listed and traded on nasdaq. News 16 days ago | N/A |
| 95 | TCS | Container Store (The) | $0.8268 | 4.66% | 5.525 K | Container Store (The)5 days ago THE CONTAINER STORE GROUP, INC. ANNOUNCES FOURTH QUARTER AND FULL FISCAL YEAR 2023 FINANCIAL RESULTS News coppell, texas--(business wire)--the container store group, inc. (nyse: tcs) (the “company”), today announced its financial results for the fourth quarter and fiscal year 2023 ended march 30, 2024. for the fourth quarter of fiscal 2023: consolidated net sales were $206.0 million, down 20.7%, compared to the fourth quarter of fiscal 2022. net sales in the container store retail business (“tcs”) were $195.3 million, down 20.4%. elfa international ab (“elfa”) third-party net sales were $10.7 milli. News 5 days ago | Hold |
| 96 | EJH | E-Home Household Service Holdings Limited | $0.73 | 4.6% | 90.166 K | E-Home Household Service Holdings Limited2 days ago E-HOME HOUSEHOLD SERVICES HOLDINGS LIMITED'S CHUANG YING BUSINESS STUDIES RELIES ON AI TECHNOLOGY TO DEVELOP ITS OWN SERVICE PLATFORM FOR PROFESSIONAL TALENTS FOR ENTERPRISE POSITIONS, ENABLING ENTERPRISES TO CULTIVATE TALENTS MORE EFFICIENTLY News fuzhou, china , may 17, 2024 /prnewswire/ -- e-home household services holdings limited (nasdaq:ejh) (the "company" or "e home"), an integrated home services provider in china, the company today announced that ehome's holding company, fujian province chuang ying business learning technology co., ltd. has developed its own enterprise professional skills learning platform system based on ai technology. News 2 days ago | N/A |
| 97 | IVP | Inspire Veterinary Partners, Inc. | $2.74 | 4.58% | 4.597 K | Inspire Veterinary Partners, Inc.4 days ago INSPIRE VETERINARY PARTNERS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS News total revenue of $4.8 million, a 13% increase compared to the prior year quarter same store sales growth, 3% year over year cost reduction initiatives implemented to improve cash management and accelerate path to free cash flow virginia beach, va / accesswire / may 15, 2024 / inspire veterinary partners, inc. (nasdaq:ivp) ("inspire" or the "company"), an owner and provider of pet health care services throughout the u.s., today reported its financial results for the first quarter ended march 31, 2024. first quarter 2024 overview total revenue of $4.8 million, an increase of 13% services revenue of $3.5 million, an increase of 15% product revenue of $1.3 million, an increase of 6% "2024 is off to a good start as we drove solid 13 percent top-line growth and believe our results highlight the broad-based growth and strong pet parent demand for our service and product offerings," said kimball carr, chairman, president & chief executive officer of inspire. News 4 days ago | N/A |
| 98 | MTC | MMTec, Inc. | $7.33 | 4.56% | 6.5 K | MMTec, Inc.11 days ago MMTEC, INC. ANNOUNCES A PAUSE ON FINANCING ACTIVITIES IN THE NEXT SIX MONTHS News hong kong , may 8, 2024 /prnewswire/ -- mmtec, inc. ("mmtec" or the "company") (nasdaq: mtc), announced that it will suspend the acceptance of new investments and pause the company's capital raising activities for the next six months. in light of the company's current capital position, combined with a comprehensive assessment of the current market environment and our business operations, our management team has decided to suspend the company's financing plans for the next six months. News 11 days ago | N/A |
| 99 | APLM | Apollomics Inc. | $0.3473 | 4.55% | 245 | Apollomics Inc.24 days ago APOLLOMICS ANNOUNCES APPROVAL OF VEBRELTINIB IN CHINA AS A FIRST-IN-CLASS TREATMENT FOR GLIOMAS WITH MET FUSION GENE News apollomics' partner in china, avistone, received approval from national medical products administration of china to expand the use of vebreltinib to the treatment of gliomas with ptprz1-met fusion gene News 24 days ago | N/A |
